Leading Life Technologies (LLT) is where better data become better research, diagnosis and cure.
LLT is committed to providing more reliable data to help scientists and clinicians make those decisions with confidence. By using our patented assay platforms, scientists and clinicians can stay ahead of the latest developments in medical research and gain the evidence they need to strengthen their decision-making and improve patient outcomes.
LLT exploits its proprietary FocalTuning™ platform to provide life science and clinical research products and services (US10,914,731B2, 2021; US11,835,517B2, 2023; ZL202080015982.5, 2024). We focus on detecting sensitive biomarkers and low level analytes in complicated biological samples.
FocalTuningTM is a universal immunoassay platform, which can be tailored and applied in a variety of research and clinical areas. Monitoring PEG immunogenicity, particularly anti-PEG IgE, is one of the breakthrough applications of this technology. Welcome to visit peg.leadinglifetechnologies.com for more details.
Vision: A next-generation diagnostics company
Mission: Better data. Better research. Better patient outcomes
Strategy: Interdisciplinary
Purpose: Improving research and health
As the year comes and goes, LLT want to extend our everlasting wishes to you and your team. Your work inspires us every day to continue providing high-quality, innovative solutions that support your life-changing research, diagnostics and therapies. We are honored to be a part of your journey.